<DOC>
	<DOCNO>NCT00762333</DOCNO>
	<brief_summary>The purpose research determine two protein blood increase acute myocardial infarction whether level high develop heart failure . These two protein produce potentially release heart muscle damage . They may release blood detect standard method research laboratory . At time , detection increase proteins blood know associated disease myocardial infarction .</brief_summary>
	<brief_title>Circulating Markers Ischemic Heart Disease</brief_title>
	<detailed_description>Hypotheses , Objectives Aims : Hypotheses : Caspase-3 , cleave activate , dystrophin detect human circulation . The level two marker elevate acute myocardial infarction . Furthermore , level two protein great develop heart failure . Objectives : - To determine whether cleaved caspase-3 dystrophin detect human circulation acute myocardial infarction - To compare serum level two marker develop heart failure Scientific Background Significance : Apoptosis regulate biological process result cell death ( 4-9 ) . Caspases , family cysteine acid protease regulate process , fact , lead apoptosis . Apoptotic trigger signal result activation proximal initiator caspase ( caspase-8 , -9 , 10 ) . These initiator caspase cleave turn activate downstream effector caspases caspases-3 , -6 -7 . These effector caspase cleave various protein present cytoskeleton nucleus like lamin A , alpha-fodrin poly ( ADP-ribose ) polymerase , lead apoptosis . Caspase-3 key executioner apoptotic pathway , responsible totally critically proteolytic cleavage cellular nuclear protein . Activation caspase-3 require proteolytic process inactive zymogen active p17 p12 fragment . The cleaved caspase-3 detected antibody specific cleave enzyme ( p17 fragment ) cell lysates immunoblotting ELISA assay utilize spectrophotometric determination microplate reader OD450 nm . Ischemia reperfusion know cause apoptosis . Therefore , acute MI may associate release final executioner apoptosis caspase-3 , circulation.Another potential marker acute deterioration dystrophin . Dystrophin originally identify x-linked gene whose mutation N-terminus cause cardiomyopathy . Dystrophin provide important structural support cardiac myocyte sarcolemmal membrane ( 10-11 ) . It link actin N-terminus dystrophin-associated protein complex sarcolemma C-terminus extracellular matrix muscle . Mutations cause loss support sarcolemmal instability myopathy . Myocardial dystrophin translocation cleavage associate progression heart failure contractile dysfunction . These change reverse follow reduction mechanical stress ventricular assistance device ( 12 ) . Since MI associate sarcolemmal instability , dystrophin may also release circulation .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<criteria>men woman , 18 year age acute myocardial infarction ( determine positive cardiac marker CKMB/ troponin ) without heart failure ( dyspnea , rale , edema , elevate jugular venous pressure , ascites ) . Heart failure diagnose use image evidence dilate heart , poor contractile function echocardiographic Doppler evidence diastolic dysfunction elevate right leftsided filling pressure A control group male subject age 60 old without history MI heart disease Subjects unable give consent Subjects undergone cardiac noncardiac surgery 3 month prior enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>